T1	Participants 80 110	patients with advanced cancer.
T2	Participants 267 370	Eighteen patients of colorectal cancer with metastases to the liver or lung or of unresectable hepatoma
T3	Participants 1159 1222	Of 18 patients 12 were evaluable for their response to therapy.
